Sponsor pipeline

AOP Orphan Pharmaceuticals AG clinical trial pipeline

Get alerts when AOP Orphan Pharmaceuticals AG's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3
2
Phase 4
1
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT06317805 Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy… Pulmonary Arterial Hypertension Recruiting 2024-03-19
Phase 3
NCT06350032 Investigational Trial to Evaluate Safety and Tolerability of Treprostinil in Children… Pulmonary Arterial Hypertension Recruiting 2025-05-31
NCT06514807 A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential… Essential Thrombocythaemia Active, Not Recruiting 2024-12-19
Not specified
NCT07736846 TREPROSTINIL in Pulmonary Hypertension: Evidence and Clinical Trends Pulmonary Arterial Hypertension (PAH) Not Yet Recruiting 2026-07-30
NCT06445673 A Prospective Non-interventional Observational Study to Observe Long-term Treatment and… Pulmonary Arterial Hypertension Enrolling by Invitation 2024-08-07

Disease areas by active trials

Hypertension (4)

Get alerts when AOP Orphan Pharmaceuticals AG's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free